Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Stem Cell Reports ; 10(2): 390-405, 2018 02 13.
Article in English | MEDLINE | ID: mdl-29337120

ABSTRACT

Cellular replacement therapies for neurological conditions use human embryonic stem cell (hESC)- or induced pluripotent stem cell (hiPSC)-derived neurons to replace damaged or diseased populations of neurons. For the spinal cord, significant progress has been made generating the in-vitro-derived motor neurons required to restore coordinated movement. However, there is as yet no protocol to generate in-vitro-derived sensory interneurons (INs), which permit perception of the environment. Here, we report on the development of a directed differentiation protocol to derive sensory INs for both hESCs and hiPSCs. Two developmentally relevant factors, retinoic acid in combination with bone morphogenetic protein 4, can be used to generate three classes of sensory INs: the proprioceptive dI1s, the dI2s, and mechanosensory dI3s. Critical to this protocol is the competence state of the neural progenitors, which changes over time. This protocol will facilitate developing cellular replacement therapies to reestablish sensory connections in injured patients.


Subject(s)
Human Embryonic Stem Cells/cytology , Induced Pluripotent Stem Cells/transplantation , Sensory Receptor Cells/cytology , Spinal Cord/growth & development , Bone Morphogenetic Protein 4/pharmacology , Cell Culture Techniques , Cell Differentiation/drug effects , Cell Differentiation/genetics , Human Embryonic Stem Cells/transplantation , Humans , Induced Pluripotent Stem Cells/cytology , Interneurons/cytology , Interneurons/transplantation , Sensory Receptor Cells/transplantation , Spinal Cord/physiopathology , Spinal Cord/transplantation , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...